A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to assess the single-dose relative bioavailability of Actavis Group
hf and Pfizer (Norvasc®) 10 mg amlodipine besylate tablets, under fed conditions.